Company intelligence / Profile preview

Food Brewer

Ownership: Private
Development stage: Preclinical

Overview

Food Brewer is a Swiss biotech startup pioneering the use of plant cell culture to produce cocoa and coffee ingredients. The company operates at pilot scale using 800-liter bioreactors, with plans to scale up to industrial levels. Their approach offers sustainable alternatives to traditional agriculture by growing plant cells in controlled environments, reducing reliance on land, water, and climate-sensitive farming. They have raised significant funding and are targeting U.S. market entry by late 2026 after regulatory filings.

Modalities: Plant cell culture
Industry: Non-Drug Biotech

Partnerships

Lindt & SprüngliSparkalisKrones Group / Steinecker

Beyond the preview

Go deeper on Food Brewer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Food Brewer.

Explore the full profile